Smoking Cessation Agents

Article

Smoking Cessation: Which Options are Best?

The field of smoking cessation has been abuzz since the FDA approved Chantix (varenicline) in 2006. Pfizer’s studies showed better efficacy for Chantix than bupropion (Wellbutrin/Zyban), and the mechanism of action is fascinating. But several controversial issues have arisen to muddy the waters. Reports of psychiatric side effects surfaced, prompting the FDA to issue a public health advisory. And on an unrelated note, a new “cold turkey” quit smoking movement has arisen, filled with critics of pharmacological cures. Let’s look at some of these issues in more detail.

Research Update

Can Instant Messaging Enhance Treatment Outcomes?

Whether you see your patients quarterly, monthly, or even weekly, you certainly are not with them as much as their cell phones are.